These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 21323814)

  • 1. Immune intervention for type 1 diabetes mellitus.
    Skyler JS
    Int J Clin Pract Suppl; 2011 Feb; (170):61-70. PubMed ID: 21323814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation for type 1 diabetes mellitus.
    Skyler JS
    Int J Clin Pract Suppl; 2010 Feb; (166):59-63. PubMed ID: 20377666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction and prevention of type 1 diabetes: progress, problems, and prospects.
    Skyler JS
    Clin Pharmacol Ther; 2007 May; 81(5):768-71. PubMed ID: 17392722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune disorders in diabetes.
    Boitard C; Debray-Sachs M; Bach JF
    Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model.
    Zhao Y; Guo C; Hwang D; Lin B; Dingeldein M; Mihailescu D; Sam S; Sidhwani S; Zhang Y; Jain S; Skidgel RA; Prabhakar BS; Mazzone T; Holterman MJ
    Biochem Biophys Res Commun; 2010 Sep; 399(4):629-36. PubMed ID: 20691153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes?
    Li DS; Warnock GL; Tu HJ; Ao Z; He Z; Lu H; Dai LJ
    Life Sci; 2009 Oct; 85(15-16):549-56. PubMed ID: 19747492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetogenic T lymphocytes in human Type 1 diabetes.
    Roep BO; Peakman M
    Curr Opin Immunol; 2011 Dec; 23(6):746-53. PubMed ID: 22051340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitus.
    Phillips BE; Giannoukakis N; Trucco M
    Pediatr Endocrinol Rev; 2008 Jun; 5(4):873-9. PubMed ID: 18552749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmacytoid dendritic cells in autoimmune diabetes - potential tools for immunotherapy.
    Nikolic T; Welzen-Coppens JM; Leenen PJ; Drexhage HA; Versnel MA
    Immunobiology; 2009; 214(9-10):791-9. PubMed ID: 19628297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
    Fändrich F; Ungefroren H
    Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T cells in type 1 diabetes.
    Tsai S; Shameli A; Santamaria P
    Adv Immunol; 2008; 100():79-124. PubMed ID: 19111164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes.
    Silveira PA; Grey ST
    Trends Endocrinol Metab; 2006; 17(4):128-35. PubMed ID: 16580840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapies aimed at preservation or restoration of beta cell function in type 1 diabetes.
    Keymeulen B
    Verh K Acad Geneeskd Belg; 2008; 70(2):85-103. PubMed ID: 18630722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
    Hummel M; Durinovic-Bello I; Ziegler AG
    J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological aspects of diabetes.
    Cheţa D
    Recenti Prog Med; 1990 Feb; 81(2):72-8. PubMed ID: 2195611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New findings on the pathogenesis of diabetes mellitus].
    Keller U
    Schweiz Med Wochenschr; 1986 Jan; 116(3):66-71. PubMed ID: 3511524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoimmunity and insulin-dependent diabetes mellitus. Experimental data and therapeutic prospects].
    Thivolet C; Khallouf E
    Pediatrie; 1989; 44(4):247-57. PubMed ID: 2677968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological disorders of type 1 diabetes mellitus.
    Ziegler M; Ziegler B
    Exp Clin Endocrinol; 1989 Sep; 94(1-2):97-114. PubMed ID: 2689194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.